Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Dermatophytosis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Dermatophytosis Drugsmarket, defines the market attractiveness level of Dermatophytosis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Dermatophytosis Drugs industry, describes the types of Dermatophytosis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Dermatophytosis Drugs market and the development prospects and opportunities of Dermatophytosis Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Dermatophytosis Drugs market in Chapter 13.
By Player:
Enzon Pharmaceuticals
Abbott
GSK
Pfizer
Bayer
Novartis
Sanofi-Aventis
Merck
Astellas Pharma
By Type:
Rx
OTC
By End-User:
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Dermatophytosis Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Dermatophytosis Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Dermatophytosis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Dermatophytosis Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Dermatophytosis Drugs Market Analysis and Outlook to 2022
-
7.1 Global Dermatophytosis Drugs Consumption (2017-2022)
-
7.2 United States Dermatophytosis Drugs Consumption (2017-2022)
-
7.3 Europe Dermatophytosis Drugs Consumption (2017-2022)
-
7.4 China Dermatophytosis Drugs Consumption (2017-2022)
-
7.5 Japan Dermatophytosis Drugs Consumption (2017-2022)
-
7.6 India Dermatophytosis Drugs Consumption (2017-2022)
-
7.7 South Korea Dermatophytosis Drugs Consumption (2017-2022)
8 Region and Country-wise Dermatophytosis Drugs Market Analysis and Outlook to 2028
-
8.1 Global Dermatophytosis Drugs Consumption Forecast (2022-2028)
-
8.2 United States Dermatophytosis Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Dermatophytosis Drugs Consumption Forecast (2022-2028)
-
8.4 China Dermatophytosis Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Dermatophytosis Drugs Consumption Forecast (2022-2028)
-
8.6 India Dermatophytosis Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Dermatophytosis Drugs Consumption Forecast (2022-2028)
9 Global Dermatophytosis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Dermatophytosis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Rx Consumption and Growth Rate (2017-2022)
-
9.1.2 Global OTC Consumption and Growth Rate (2017-2022)
-
9.2 Global Dermatophytosis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Dermatophytosis Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Dermatophytosis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Rx Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Dermatophytosis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Dermatophytosis Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Dermatophytosis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Dermatophytosis Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Dermatophytosis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Dermatophytosis Drugs Market Competitive Analysis
-
14.1 Enzon Pharmaceuticals
-
14.1.1 Enzon Pharmaceuticals Company Details
-
14.1.2 Enzon Pharmaceuticals Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Enzon Pharmaceuticals Dermatophytosis Drugs Product and Service
-
14.2 Abbott
-
14.2.1 Abbott Company Details
-
14.2.2 Abbott Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Abbott Dermatophytosis Drugs Product and Service
-
14.3 GSK
-
14.3.1 GSK Company Details
-
14.3.2 GSK Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GSK Dermatophytosis Drugs Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Dermatophytosis Drugs Product and Service
-
14.5 Bayer
-
14.5.1 Bayer Company Details
-
14.5.2 Bayer Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer Dermatophytosis Drugs Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Dermatophytosis Drugs Product and Service
-
14.7 Sanofi-Aventis
-
14.7.1 Sanofi-Aventis Company Details
-
14.7.2 Sanofi-Aventis Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi-Aventis Dermatophytosis Drugs Product and Service
-
14.8 Merck
-
14.8.1 Merck Company Details
-
14.8.2 Merck Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Merck Dermatophytosis Drugs Product and Service
-
14.9 Astellas Pharma
-
14.9.1 Astellas Pharma Company Details
-
14.9.2 Astellas Pharma Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Astellas Pharma Dermatophytosis Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Dermatophytosis Drugs
-
Figure Dermatophytosis Drugs Picture
-
Table Global Dermatophytosis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dermatophytosis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dermatophytosis Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Dermatophytosis Drugs Consumption by Country (2017-2022)
-
Figure United States Dermatophytosis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Dermatophytosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Dermatophytosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Dermatophytosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Dermatophytosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Dermatophytosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Dermatophytosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Dermatophytosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Dermatophytosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Dermatophytosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Dermatophytosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Dermatophytosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Dermatophytosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rx Consumption and Growth Rate (2017-2022)
-
Figure Global OTC Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Rx Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Dermatophytosis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Dermatophytosis Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Enzon Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Enzon Pharmaceuticals Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enzon Pharmaceuticals Dermatophytosis Drugs Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Dermatophytosis Drugs Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Dermatophytosis Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Dermatophytosis Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Dermatophytosis Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Dermatophytosis Drugs Product and Service
-
Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis Dermatophytosis Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Dermatophytosis Drugs Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Dermatophytosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Dermatophytosis Drugs Product and Service
-
